Hypertensive disease of pregnancy and maternal mortality

Current Opinion in Obstetrics and Gynecology

Volumn 25, Issue 2, 2013, Pages 124-132

  Lo, Jamie O ^a   Mission, John F ^a   Caughey, Aaron B ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

hypertension; mortality; preeclampsia; pregnancy

Indexed keywords

ANTICONVULSIVE AGENT; HYDRALAZINE; LABETALOL; MAGNESIUM SULFATE; NIFEDIPINE; NIMODIPINE; PHENYTOIN;

ADULT RESPIRATORY DISTRESS SYNDROME; BLEEDING; BLOOD PRESSURE REGULATION; BRADYCARDIA; CARDIOPULMONARY ARREST; CARDIOVASCULAR MORTALITY; CHRONIC HYPERTENSION; CONVULSION; CROSS-SECTIONAL STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE CONTROL; DISSEMINATED INTRAVASCULAR CLOTTING; DRUG INDUCED HEADACHE; ECLAMPSIA; HEALTH CARE ORGANIZATION; HEART PALPITATION; HELLP SYNDROME; HEMOLYSIS; HUMAN; HYPOXIC ISCHEMIC ENCEPHALOPATHY; LONG TERM CARE; MATERNAL HYPERTENSION; MATERNAL MORTALITY; PREECLAMPSIA; PRENATAL CARE; PRIORITY JOURNAL; RACE DIFFERENCE; REVIEW; SEIZURE; SEPSIS; TACHYCARDIA; UNITED STATES;

ANTIHYPERTENSIVE AGENTS; ECLAMPSIA; FEMALE; HUMANS; HYPERTENSION, PREGNANCY-INDUCED; INCIDENCE; MAGNESIUM SULFATE; MATERNAL MORTALITY; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PRENATAL CARE; RISK FACTORS; TOCOLYTIC AGENTS; UNITED STATES;

EID: 84874949131     PISSN: 1040872X     EISSN: 1473656X     Source Type: Journal    
DOI: 10.1097/GCO.0b013e32835e0ef5     Document Type: Review

References (53)

1. Wagner SJ, Barac S, Garovic VD. Hypertensive pregnancy disorders: current concepts. J Clin Hypertens 2007; 9:560-566.
2. Martin JN, Hamilton BE, Sutton PD, et al. Births: final data for 2006. Natl Vital Stat Rep 2009; 57.
3. Berg CJ, Chang J, Callaghan WM, et al. Pregnancy-related mortality in the United States 1991-1997. Obstet Gynecol 2003; 101:289.
4. Saudan P, Brown MA, Buddle ML, Jones M. Does gestational hypertension become preeclampsia? BJOG 1998; 105:1177-1184.
5. Kuklina EV, Ayala C, Callaghan WM. Hypertensive disorders and severe obstetric morbidity in the United States. Obstet Gynecol 2009; 113:1299-1306.
6. Hutcheon JA, Lisonkova S, Joseph KS. Epidemiology of preeclampsia and the other hypertensive disorders of pregnancy. Best Pract Res Clin Obstet Gynaecol 2011; 25:391-403.
7. Ventura SJ, Martin JA, Curtin SC, et al. Births: final data for 1998. Natl Vital Stat Rep 2000; 48.
8. Royal College of Obstetricians and Gynaecologist. The management of severe preeclampsia. RCOG Guideline. 2006; 10A:1.
9. Wallis AB, Saftlas AF, Hsia J, et al. Secular trends in the rates of preeclampsia, eclampsia, and gestational hypertension in the United States, 1987-2004. Am J Hypertens 2009; 21:521-526.
10. Chhabra S, Kakani A. Maternal mortality due to eclamptic and noneclamptic hypertensive disorders: a challenge. J Obstet Gynecol 2007; 27:25-29.
11. Report of the National High Blood Pressure Education Program Working Group on high blood pressure in pregnancy. Am J Obstet Gynecol 2000; 183:S1-S22.
12. Duley L. Maternal mortality associated with hypertensive disorders of pregnancy in Africa, Asia, Latin America and Caribbean. Br J Obstet Gynaecol 1992; 99:547-553.
13. Walker GJ, Ashley DE, McCaw AM, Bernard GW. Maternal mortality in Jamaica. Lancet 1986; 1:486-488.
14. Zarcian A. Hypertensive disorder of pregnancy. Int J Gynecol Obstet 2004; 87:194-198.
15. Yucesoy G, Ozkan S, Bodur H, et al. Maternal and perinatal outcome in pregnancies complicated with hypertensive disorders of pregnancy: a seven year experience of a tertiary care center. Arch Gynecol Obstet 2005; 273:43-49.
16. Isler CM, Rinehart BK, Terrone DA, et al. Maternal mortality associated with HELLP (hemolysis, elevated liver enzymes, and low platelets) syndrome. Am J Obstet Gynecol 1999; 181:924-928.
17. Zhang J, Meikle S, Trumble A. Severe maternal morbidity associated with hypertensive disorders in pregnancy in the United States. Hypertens Pregnancy 2003; 22:203-212.
18. Beck DW, Menezes MB. Intracerebral hemorrhage in a patient with eclampsia. JAMA 1981; 246:1442-1443.
19. Martin JN Jr, Thigpen BD, Moore RC, et al. Stroke and severe preeclampsia and eclampsia: a paradigm shift focusing on systolic blood pressure. Obstet Gynecol 2005; 105:246-254.
20. Khan KS, Wojdyla D, Say L, et al. WHO analysis of causes of maternal death: a systematic review. Lancet 2006; 367:1066-1074.
21. Schutte JM, Steegers EAP, Schuitemaker NEW, et al. Rise in maternal mortality in the Netherlands. BJOG 2010; 117:399-406.
22. Martin JN, Hamilton BE, Ventura SJ, et al. Births: final data for 2009. Natl Vital Stat Rep 2011; 60.
23. Mackay AP, Berg CJ, Atrash HK. Pregnancy-related mortality from preeclampsia and eclampsia. Obstet Gynecol 2001; 97:533-538.
24. Tanaka M, Jaamaa G, Kaiser M, et al. Racial disparity in hypertensive disorders of pregnancy in New York state: a 10-year longitudinal population-based study. Am J Public Health 2007; 97:163-170.
25. Bryant AS, Worioloh A, Caughey AB, Washington AE. Racial/ethnic disparities in obstetric outcomes and care: prevalence and determinants. Am J Obstet Gynecol 2010; 202:335-343.
26. Healy AJ, Malone FD, Sullivan LM, et al. Early access to prenatal care: implications for racial disparity in perinatal mortality. Obstet Gynecol 2006; 107:625-631.
27. Samadi AR, Mayberry RM, Zaidi AA, et al. Maternal hypertension and associated pregnancy complications among African-American and other women in the United States. Obstet Gynecol 1996; 87:557-563.
28. Wong LF, Caughey AB, Nakagawa S, et al. Perinatal outcomes among different Asian-American subgroups. Am J Obstet Gynecol 2008; 199: 382.e1-382.e6.
29. Rao AK, Daniels K, El-Sayed YY, et al. Perinatal outcomes among Asian American and Pacific Islander women. Am J Obstet Gynecol 2006; 195:834-838.
30. Rao AK, Cheng YW, Caughey AB. Perinatal complications among different Asian-American subgroups. Am J Obstet Gynecol 2006; 194:e39-e41.
31. Caughey AB, Stotland NE, Washington AE, Escobar GJ. Maternal ethnicity, paternal ethnicity, and parental ethnic discordance: predictors of preeclampsia. Obstet Gynecol 2005; 106:156-161.
32. Kung HC, Hoyert DI, Xu J, Murphy SL. Deaths: final data for 2005. Natl Vital Stat Rep 2008; 56:1-120.
33. Tucker MJ, Berg CJ, Callaghan WM, Hsia J. The Black-White disparity in pregnancy-related mortality from 5 conditions: differences in prevalence and case-fatality rates. Am J Public Health 2007; 97:247-251.
34. Saving mothers' lives: reviewing maternal deaths to make motherhood safer: 2006-08. The Eighth Report on Confidential Enquiries into Maternal Deaths in the United Kingdom. Centre for Maternal and Child Enquiries (CMACE). BJOG 2011; 118(Suppl. 1):1-203.
35. Committee opinion no. 514: emergent therapy for acute-onset, severe hypertension with preeclampsia or eclampsia. Committee on Obstetric Practice. Obstet Gynecol 2011; 118:1465-1468.
36. Menzies J, Magee LA, Li J, et al. Instituting surveillance guidelines and adverse outcomes in preeclampsia. Preeclampsia Integrated Estimate of Risk (PIERS) Study Group. Obstet Gynecol 2007; 110:121-127.
37. Von Dadelszen P, Sawchuck D, McMaster R, et al. The active implementation of pregnancy hypertension guidelines in British Columbia. Translating Evidence-Based Surveillance and Treatment Strategies (TESS) Group. Obstet Gynecol 2010; 116:659-666.
38. Tuffnell DJ, Jankowicz D, Lindow SW, et al. Outcomes of severe preeclampsia/eclampsia in Yorkshire 1999/2003. BJOG 2005; 112:875-880.
39. Magee LA, Cham C, Waterman EJ, et al. Hydralazine for treatment of severe hypertension in pregnancy: meta-analysis. BMJ 2003; 327:955-960.
40. Raheem IA, Saaid R, Omar SZ, Tan PC. Oral nifedipine versus intravenous labetalol for acute blood pressure control in hypertensive emergencies of pregnancy: a randomized trial. BJOG 2012; 119:78-85.
41. Altman D, Carroli G, Duley L, et al., Magpie Trial Collaboration Group. Do women with preeclampsia and their babies benefit from magnesium sulfate? The Magpie trial: a randomized placebo-controlled trial. Lancet 2002; 359:1877-1890.
42. Belfort MA, Anthony J, Saade GR, Allen JC. A comparison of magnesium sulfate and nimodipine for the prevention of eclampsia. N Engl J Med 2003; 348:304-311.
43. Lucas MJ, Leveno KJ, Cunningham FG. A comparison of magnesium sulfate with phenytoin for the prevention of eclampsia. N Engl J Med 1995; 333:201-205.
44. Duley L, Gulmezoglu AM, Henderson-Smart DJ, Chou D. Magnesium sulfate and other anticonvulsants for women with preeclampsia. Cochrane Database Syst Rev 2010; (11):CD000025.
45. Magpie Trial Follow-up Collaborative Group. The Magpie Trial: a randomized trial comparing magnesium sulphate with placebo for preeclampsia. Outcome for women at 2 years. BJOG 2007; 114:300-309.
46. Lykke JA, Paidas MJ, Langhoof-Roos J. Recurring complications in second pregnancy. Obstet Gynecol 2009; 113:1217-1224.
47. Hjartardottir S, Leifsson B, Geirsson R, et al. Recurrence of hypertensive disorder in second pregnancy. Am J Obstet Gynecol 2006; 194:916-920.
48. Bellamy L, Casas JP, Hingorani AD, et al. Preeclampsia and risk of cardiovascular disease and cancer in later life: systemic review and meta-analysis. BMJ 2007; 335:974.
49. Mcdonald SD, Malinowski A, Zhou Q, et al. Cardiovascular sequelae of preeclampsia/eclampsia: a systemic review and meta-analyses. Am Heart J 2008; 156:918-930.
50. Aukes AM, de Groot JC, Aarnoudse JG, et al. Brain lesions several years after eclampsia. Am J Obstet Gynecol 2009; 200:504.
51. Aukes AM, de Groot JC, Wiegman MJ, et al. Long-term cerebral imaging after preeclampsia. BJOG 2012; 119:1117-1122.
52. Wiegman MJ, de Groot JC, Jansonius NM, et al. Long-term visual functioning after eclampsia. Obstet Gynecol 2012; 119:959-966.
53. Vikse BE, Irgens LM, Leivestad T, et al. Preeclampsia and the risk of end-stage renal disease. N Engl J Med 2008; 359:800.